Do’s & Don’ts of DEA Compliance for Ambulatory Medicine

Presentation goal: Make any and all working with or handling-controlled substances aware of their role in maintaining best practices to ensure overall compliance. We’ll discuss: DEA audits and inspections, documentation needed in an investigation, liability, the Controlled Substance Act of 1970, identifying risks, recordkeeping and reconciliations, fines, consequences, and the long-term effects of non-compliance.

Speaker

Jack Teitelman
Jack Teitelman is a retired DEA Supervisory Special Agent with over 26 years of experience fighting the illegal trafficking of narcotics and controlled substances. Jack joined the DEA in 1988 upon earning a bachelor’s degree in criminal justice from the University of North Florida. That same year, Jack graduated from the FBI Academy, Quantico, VA, and was assigned to the DEA New York Division, where he spent the first eight years of his career before being promoted to Supervisory Special Agent and transferred to the Atlanta Technical Operations Group.

Over his 26-year career with the DEA, Jack gained extensive experience in all facets of complex criminal drug conspiracy investigations and won numerous awards and commendations for the work he led to take down numerous drug trafficking organizations both in the U.S. and internationally.

Jack retired from the DEA in 2015 and today heads TITAN Group, a DEA regulatory consulting firm that is an industry leader providing regulatory compliance services to a broad range of human and animal healthcare industries.

Online equine CE is presented by